167 related articles for article (PubMed ID: 37806747)
21. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
Zahra S; Zaib S; Khan I
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
[TBL] [Abstract][Full Text] [Related]
22. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
23. Insights into the leaves of Ceriscoides campanulata: Natural proanthocyanidins alleviate diabetes, inflammation, and esophageal squamous cell cancer via in vitro and in silico models.
Uddin MJ; Faraone I; Haque MA; Rahman MM; Halim MA; Sönnichsen FD; Çiçek SS; Milella L; Zidorn C
Fitoterapia; 2022 Apr; 158():105164. PubMed ID: 35217120
[TBL] [Abstract][Full Text] [Related]
24. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM
Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061
[TBL] [Abstract][Full Text] [Related]
26. Potential antioxidant, α-glucosidase, butyrylcholinesterase and acetylcholinesterase inhibitory activities of major constituents isolated from
Al Garni HA; El-Halawany AM; Koshak AE; Malebari AM; Alzain AA; Mohamed GA; Ibrahim SRM; El-Sayed NS; Abdallah HM
SAR QSAR Environ Res; 2024 May; 35(5):391-410. PubMed ID: 38769919
[No Abstract] [Full Text] [Related]
27. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
Molecules; 2023 May; 28(10):. PubMed ID: 37241920
[TBL] [Abstract][Full Text] [Related]
29. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases.
Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA
Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518
[TBL] [Abstract][Full Text] [Related]
30. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
31. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
32. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
[No Abstract] [Full Text] [Related]
33. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
34. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations.
Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
37. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies.
Abbasi MA; Hassan M; Ur-Rehman A; Siddiqui SZ; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY
Comput Biol Chem; 2018 Dec; 77():72-86. PubMed ID: 30245349
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
[TBL] [Abstract][Full Text] [Related]
39. Bio-Potency and Molecular Docking Studies of Isolated Compounds from
Ul Bari W; Ur Rehman N; Khan A; Ahsan Halim S; Yuan Y; Blaskovich MAT; Ziora ZM; Zahoor M; Naz S; Ullah R; Alotaibi A; Al-Harrasi A
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916198
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
